GM, Pfizer, and Harley-Davidson: Stock Outlook & Strategy
This paper examines the near-term stock price outlook and strategic process types of three major U.S. corporations: General Motors, Pfizer, and Harley-Davidson. For GM, continued growth and R&D investment support a positive stock outlook. Pfizer faces headwinds from FDA scrutiny, lawsuits, and drug recalls that limit near-term upside. Harley-Davidson's expansion into the Chinese market introduces uncertainty while its domestic brand prestige remains a durable competitive advantage. The paper also explores how each company's process type influences its ability to reach target market capacity, considering regulatory environments, brand identity, and market share dynamics.
- Stock Price Outlook for the Next Year: One-year stock forecasts for GM, Pfizer, and Harley-Davidson
- Process Type and Rationale: How each company's operational process type fits its industry
- Harley-Davidson's Brand Identity and Competitive Advantage: Prestige, lifestyle branding, and Harley-Davidson's marketing edge
- Process Type and Its Effect on Target Market Capacity: Process type's role in capturing maximum market share
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper uses a clear parallel structure, addressing each company in turn across multiple analytical dimensions (stock outlook and process type), making comparisons easy to follow.
- It connects macroeconomic context — such as FDA regulation and international market entry — to firm-level stock performance, demonstrating awareness of external forces.
- The Harley-Davidson section effectively links intangible brand equity (lifestyle, prestige, cultural identity) to concrete business outcomes like market share and pricing power.
Key academic technique demonstrated
The paper demonstrates comparative business analysis by evaluating three firms across identical analytical categories. Rather than treating each company in isolation, the author draws implicit contrasts — particularly between GM's manufacturing process, Pfizer's regulation-constrained model, and Harley-Davidson's brand-driven strategy — to show how process type shapes competitive outcomes differently across industries.
Structure breakdown
The paper opens with a three-part stock outlook section covering GM, Pfizer, and Harley-Davidson sequentially. It then pivots to a process-type analysis, again moving through all three companies with the Harley-Davidson discussion expanded into brand identity and marketing. A final integrating section ties process type to target market capacity before a short bibliography closes the paper. The structure is straightforward and well-suited to an undergraduate business course format.
Stock Price Outlook for the Next Year
General Motors (GM) has a good outlook for its stock price over the next year. It has often been said that what is good for GM is good for America — meaning that the health of the stock market and the broader American economy is closely tied to how the largest companies are performing (Levinson, 2006). When the American economy does well, large companies tend to do well, and vice versa. As one of the largest automakers in the world, General Motors exerts significant influence on the stock market, and the country is affected by how well the company performs. Fortunately for both the American public and the American stock market, General Motors is continuing to grow, and its research and development of vehicles that consumers want to buy is increasing (Levinson, 2006). This is allowing the company to build not only greater market share but also more revenue and income. By doing so, GM is able to acquire new technology, pay down debt, expand, hire more workers, and accomplish countless other tasks — both large and small — that help the economy continue to prosper within the United States.
For Pfizer, things are somewhat different. While large drug makers are still showing strong revenue and profit margins, they are running into increasing trouble with the FDA and other governing bodies that oversee the pharmaceutical industry. They are also facing problems with lawsuits and drugs being removed from the market due to safety concerns, side effects, and patient deaths (Barrett, 2005). The recalls and lawsuits are taking a toll on all major drug makers, and as a result it appears that Pfizer's stock will not rise significantly within the next year. It is possible that this outlook could change due to new FDA regulation or a breakthrough drug brought to market, but for now these outcomes appear unlikely (Barrett, 2005). The Pfizer Company will not disappear or go bankrupt, however, because it has too many medications generating strong market share and revenue. The company still performs well overall; it simply appears that the next year will not be one of significant stock market growth for Pfizer.
Harley-Davidson's stock price outlook is more difficult to predict. In general, the company has performed steadily and well throughout its history, but it recently moved into the Chinese market (Sui, 2006). At present, the expensive motorcycles are not well-received by Chinese consumers — primarily because of the high duty taxes, rules, and regulations imposed on them in that country. It is believed that this will change over time, and when it does, Chinese consumers will be able to purchase and ride the motorcycles more freely in cities and on public roads. Currently, Harley-Davidson engines are too large to be legal in most Chinese cities, and many roads are not safe for riders, as China records a high number of traffic fatalities each year due to unsafe driving and inconsistently enforced road rules (Sui, 2006). When these conditions improve, the Chinese market will become far more lucrative and Harley-Davidson's stock price will likely rise; for now, however, it seems that the stock will remain relatively close to its current level (Sui, 2006).
References
Barrett, A. (2005, February). Pfizer's funk. BusinessWeek Online. Retrieved from EBSCO HOST Academic Search Premier Database.
Levinson, W. (2006, January). On the road again. Industrial Engineer: IE, (28). Retrieved from EBSCO HOST Business Source Premier Database.
Sui, C. (2006, April 11). Harleys face tough China road. Motoring iAfrica.com. Retrieved from
Create your account
Always verify citation format against your institution’s current style guide requirements.